Filing Details
- Accession Number:
- 0001140361-23-002783
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-25 21:00:30
- Reporting Period:
- 2023-01-23
- Accepted Time:
- 2023-01-25 21:00:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1746473 | Pliant Therapeutics Inc. | PLRX | Pharmaceutical Preparations (2834) | 474272481 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1809204 | Lamont Keith Cummings | C/O Pliant Therapeutics, Inc. 260 Littlefield Avenue South San Francisco CA 94080 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-01-23 | 12,500 | $2.08 | 96,924 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-01-23 | 17,500 | $6.22 | 114,424 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-01-23 | 30,000 | $35.00 | 84,424 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2023-01-23 | 12,500 | $0.00 | 12,500 | $2.08 |
| Common Stock | Stock Option (right to buy) | Disposition | 2023-01-23 | 17,500 | $0.00 | 17,500 | $6.22 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 133,597 | 2029-01-23 | No | 4 | M | Direct | |
| 18,198 | 2030-03-30 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 5, 2021, as amended on August 29, 2022.
- 25% of the shares subject to such option vested on December 31, 2019 and 1/48th of the shares subject to the option vest in substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
- 1/48th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of March 31, 2020 (or if there is no corresponding day in any such month, on the last day of such month), subject to the Reporting Person's continuous service to the Issuer on each such date.
Billionaire Hedge Funds
